FDA Seeks Public Input on New In‑Home Opioid Disposal Standards

Translate to Spanish or other 102 languages!

The U.S. Food and Drug Administration today issued a Request for Information (RFI)seeking public comment on potential new standards for in-home opioid disposal products. This effort is part of the agency’s broader work to combat the opioid crisis. Image for illustration purposes
The U.S. Food and Drug Administration today issued a Request for Information (RFI)seeking public comment on potential new standards for in-home opioid disposal products. This effort is part of the agency’s broader work to combat the opioid crisis. Image for illustration purposes
- Advertisement -

The U.S. Food and Drug Administration today issued a Request for Information (RFI) seeking public comment on potential new standards for in-home opioid disposal products. This effort is part of the agency’s broader work to combat the opioid crisis.

Companies selling opioid analgesics are currently required to make available prepaid mail-back envelopes to outpatient pharmacies and other dispensers. Now, the agency is considering whether to require that opioid sponsors, through dispensers, make available in-home disposal systems.

“Having unused opioids laying around at home can be a significant risk to those struggling with opioids and can be a gateway for opioid-naïve family members,” said FDA Commissioner Marty Makary, M.D., M.P.H. “We need to develop creative ways to address opioid misuse and abuse.”

- Advertisement -

At present, FDA recommends dropping off unused opioids at a drug take-back location or mailing them back using a pre-paid envelope provided by a pharmacy. Alternatively, the FDA recommends flushing unused opioids down the toilet (something the agency only recommends for certain high-risk medications). A 2017 study in the Science of Total Environment concluded that flushing unused opioids presents a “negligible eco-toxicological risk.”

Today’s RFI seeks input from industry, health care providers, and advocates on appropriate criteria for in-home disposal kits. This aligns with the SUPPORT for Patients and Communities Reauthorization Act of 2025, which mandates the FDA to issue guidance to facilitate in-home safe disposal, as well as President Trump’s Great American Recovery initiative.  

Responses to the RFI are due by 11:59 p.m. Eastern Time on April 6, 2026. All interested parties are invited to submit comments to the docket.

Information source: FDA

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Eating and sleeping later associated with increased health risks

Staying up late and eating later in the evening could increase the risk of metabolic syndrome, a term that refers to conditions that increase the risk of type 2 diabetes, cardiovascular disease, and high cholesterol.

Health Officials Release Joint Statement Regarding Loss of U.S. Measles Elimination Status

CDC and its partners are committed to stopping measles outbreaks, protecting Americans, and regaining measles elimination status.

Why Kids Need Less Screen Time Before Bed

Phone notifications can feel nonstop – even for kids. Brian Chen, MD, a sleep specialist with Cleveland Clinic Children's, said it’s important to make sure those are muted and that screens are limited before bedtime.

Keep Thanksgiving Stress-Free with STHS Food Safety Tips

The holiday season is a time for gathering with loved ones, celebrating family traditions and enjoying home-cooked meals. 
- Advertisement -